Genzyme

LUMIZYME

Manufacturer:

Genzyme

Lumizyme HCPCS:

J0221

HCPCS Code Descriptor:

Injection, alglucosidase alfa, (lumizyme), 10 mg

Category:

J Code

Lumizyme NDCs:

58468-0160-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Lumizyme:

LUMIZYME is an Enzyme Replacement Therapy drug manufactured by Genzyme and administered via the Intravenous route of administration. The J Code: J0221 is aligned to the drug LUMIZYME.

ACCESS PRICING AND MORE BY REGISTERING

J0221 Added Date:

January 1, 2012

J0221 Effective Date:

January 1, 2012

J0221 Termination Date:

HCPCS Active

Lumizyme billing and coding information can be found through Genzyme at the link below:
Lumizyme patient assistance information can be found through CareConnectPSS at the URL: https://www.lumizyme.com/patients/patient_services/co-pay_assistance_program
LUMIZYME prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for LUMIZYME. Please check back in a few weeks.